Article Sidebar
Published:
Jan 3, 2018Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
In vitro assessment of activity of graphene silver composite sheets against multidrug-resistant bacteria and Tomato Bushy Stunt Virus
Abstract
Purpose: To synthesize graphene-based silver nanocomposites and evaluate their antimicrobial and anti-Tomato Bushy Stunt Virus (TBSV) activities.
Methods: A graphene-based silver composite was prepared by adsorbing silver nanoparticles AgNPs to the surfaces of graphene oxide (GO) sheets. Scanning electron microscopy was used to analyze the morphology of the synthesized graphene-based silver nanocomposite. This compound was investigated for its antimicrobial activity against several multidrug-resistant human pathogens using the agar well diffusion technique. Moreover, the biocompatibility and antiviral activity of the graphene-based nanocomposite against TBSV was studied in lettuce.
Results: The graphene-based silver composite exhibited remarkable antimicrobial effects against pathogenic bacteria including Shigella sonnei and Pseudomonas aeruginosa with zones of inhibition of 32 ± 0.11 and 29 ± 0.05 mm, respectively. They inhibited TBSV better than graphene and GO.
Conclusion: The synthesized graphene-based silver composite exhibits potent activity against TBSV and multidrug resistant bacteria, indicating that they are good candidates for future therapeutic applications.
Keywords: Graphene oxide, Graphene-based nanocomposite, Antiviral, Antimicrobial, Multidrugresistant (MDR) human pathogens
